Patients with OSA have also been shown to have increased levels of other inflammatory markers, such as interleukin 6 (IL-6) and C-reactive protein (CRP), which play significant roles in the inflammatory pathways activated by intermittent hypoxia [20]. The gene discussed is CRP; the disease is obstructive sleep apnea syndrome.